Long-term safety considerations Extended IGF-1 LR3 use requires vigilant attention to potential systemic effects: Organ Development : Monitor for potential enlargement of internal organs, particularly the heart and intestines Blood Sugar Management : Regular glucose monitoring becomes essential Cellular Growth : Careful observation for any unusual tissue growth The key to long-term safety lies in proper cycling protocols and regular health screenings
Clinical signs are indistinct and include lethargy, depression, ataxia, anorexia and intermittent vomiting, and in severe cases, can induce neurological disease and blindness in cats
Numerous regions of the brain express GLP-1 receptors which together synergistically impact food intake and reward-based behavior
Wang KC, Woung LC, Tsai MT, Liu CC, Su YH, Li CY
Mol Cell Endocrinol 2009
Its active medicine is a combination of levocarnitine and vitamin E